The role of IL-33 in depression: a systematic review and meta-analysis
Frontiers in Psychiatry · 01.11.2023 · 14
DOI: 10.3389/fpsyt.2023.1242367 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Psychiatry, online erschienen am 01.11.2023. Verfasst von Renli Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Education Department of Jilin Province.
Themen: Depression
Abstract (Originalsprache)
Depression has long been considered a disease involving immune hyperactivation. The impact of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8 on depression has been widely studied. However, the effect of IL-33, another pro-inflammatory cytokine, has been less researched. Currently, research on the correlation between IL-33 and depression risk is inconsistent. In response to these divergent results, we conducted a review and meta-analysis aimed at resolving published research on the correlation between IL-33 and depression risk, and understanding the potential role of IL-33 in the development and treatment of depression. After searching different databases, we analyzed 8 studies. Our meta-analysis showed that IL-33 had a positive correlation with reduced risk of depression. The pooled standard mean differences (SMD) = 0.14, 95% confidence interval (CI): 0.05–0.24. Subgroup analysis results showed that IL-33 and ST2 levels in cerebrospinal fluid and serum is positive correlated with reduced risk of major depressive disorder (MDD) and bipolar disorder (BD). According to the characteristics of the included literature, the results mainly focuses on Caucasian. Furthermore, according to the subgroup analysis of depression-related data sources for disease or treatment, the correlation between IL-33 and depression risk is reflected throughout the entire process of depression development and treatment. Therefore, the change of IL-33 level in serum and cerebrospinal fluid can serve as useful indicators for assessing the risk of depression, and the biomarker provides potential treatment strategies for reducing the burden of the disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
- Department of Pathology, The First Hospital of Jilin University, Changchun, China.
- Department of Immunology, College of Basic Medical Sciences, Jilin University, Changchun, China.
Förderung
- Education Department of Jilin Province
Zitieren
APA
Liu, R., Liu, L., Ren, S., Wei, C., Wang, Y., Li, D., & Zhang, W. (2023). The role of IL-33 in depression: a systematic review and meta-analysis. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1242367
Vancouver
Liu R, Liu L, Ren S, Wei C, Wang Y, Li D, et al. The role of IL-33 in depression: a systematic review and meta-analysis. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1242367
BibTeX
@article{Liu2023,
author = {Liu, Renli and Liu, Liping and Ren, Shiying and Wei, Chaojie and Wang, Ying and Li, Dong and Zhang, Wenxin},
title = {The role of IL-33 in depression: a systematic review and meta-analysis},
journal = {Frontiers in Psychiatry},
year = {2023},
volume = {14},
doi = {10.3389/fpsyt.2023.1242367}
}
EUVIMED